PR Newswire LAS VEGAS, Feb. 21, 2019 /PRNewswire/ -- GNCC Capital, Inc. (GNCP) ("The Company" or "GNCC") announces that it has acquired a 100% interest in BioCann Pharma S.A.S. ("BioCann"), a Cannabis CBD Pharmaceutical Grade Oils Producer and Distributor, incorporated in and operating in the Republic of Colombia ("Colombia") and with offices in Burlington, Ontario, Canada.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.